Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 4,309,586 |
|
|||||
| News | (1) | ||||||
| Day High | 14.49 | Low High |
|||||
| Day Low | 8.80 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kyverna Therapeutics Inc | KYTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -5.12 | -35.46% | 9.32 | 23:00:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.22 | 8.80 | 14.49 | 9.53 | 14.44 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 29,943 | 4,309,586 | US$ 9.94 | US$ 42,817,212 | - | 8.80 - 35.01 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:57:05 | 11 | US$ 9.64 | USD |
Kyverna Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 388.63M | 40.82M | - | 0 | -60.37M | -1.48 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kyverna Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KYTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.14 | 16.64 | 8.80 | 13.92 | 625,119 | -3.82 | -29.07% |
| 1 Month | 15.32 | 17.06 | 8.80 | 13.49 | 482,542 | -6.00 | -39.16% |
| 3 Months | 27.05 | 27.32 | 8.80 | 17.16 | 447,835 | -17.73 | -65.55% |
| 6 Months | 34.25 | 35.01 | 8.80 | 21.01 | 441,101 | -24.93 | -72.79% |
| 1 Year | 34.25 | 35.01 | 8.80 | 21.01 | 441,101 | -24.93 | -72.79% |
| 3 Years | 34.25 | 35.01 | 8.80 | 21.01 | 441,101 | -24.93 | -72.79% |
| 5 Years | 34.25 | 35.01 | 8.80 | 21.01 | 441,101 | -24.93 | -72.79% |
Kyverna Therapeutics Description
| Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna¿s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. |
